HIV Prevention Clinical Trials

34 recruiting

HIV Prevention Trials at a Glance

38 actively recruiting trials for hiv prevention are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Not Applicable with 29 trials, with the heaviest enrollment activity in Pathum Wan, Lilongwe, and Baltimore. Lead sponsors running hiv prevention studies include Institute of HIV Research and Innovation Foundation, Thailand, University of North Carolina, Chapel Hill, and University of California, Los Angeles.

Browse hiv prevention trials by phase

Treatments under study

About HIV Prevention Clinical Trials

Looking for clinical trials for HIV Prevention? There are currently 34 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new HIV Prevention trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about HIV Prevention clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 38 trials

Recruiting

Mobile Vehicle-Based Delivery of Lenacapavir Pre-Exposure Prophylaxis in Los Angeles County

HIV Prevention
University of California, Los Angeles100 enrolled1 locationNCT07467018
Recruiting
Not Applicable

The Implementation of a Trans-tailored Harm Reduction Service for Transgender Persons in Relation to chemsEX and Substance Use (iT-REX)

Substance UseMental Health DisordersHIV Prevention+2 more
Institute of HIV Research and Innovation Foundation, Thailand140 enrolled1 locationNCT07512856
Recruiting
Not Applicable

Integrating Sexual Pleasure Into Harm Reduction Services for Men Who Have Sex With Men and Transgender Persons Who Engage in Chemsex or Substance Use in Thailand

Mental HealthSubstance UseHIV Prevention+2 more
Institute of HIV Research and Innovation Foundation, Thailand300 enrolled1 locationNCT07509853
Recruiting

Host Led Harm Reduction Approach Among Men Who Have Sex With Men Who Engaged in Chemsex in Bangkok, Thailand: A Pre-Implementation Study

Mental HealthSubstance UseHIV Prevention+1 more
Institute of HIV Research and Innovation Foundation, Thailand76 enrolled1 locationNCT07512869
Recruiting
Not Applicable

California MEPS Hub

Substance Use Disorder (SUD)HIV PreventionHepatitis C Virus (HCV)+3 more
University of California, Los Angeles318 enrolled3 locationsNCT07433985
Recruiting

Pre-implementation Study to Develop Trans-tailored Services for Transgender Persons in Relation to chemsEX

Substance UseHIV PreventionSexually Transmitted Infections (STIs)
Institute of HIV Research and Innovation Foundation, Thailand50 enrolled1 locationNCT07505875
Recruiting
Not Applicable

Evaluation of mHealth Intervention to Promote HIV Prevention and Overcome Stigma Among Transgender Women (EMPOW.HER)

HIV Prevention
Institute of HIV Research and Innovation Foundation, Thailand108 enrolled3 locationsNCT07509827
Recruiting
Not Applicable

A Multi-Level Trauma-Informed Approach to Increase HIV Pre-exposure Prophylaxis Initiation Among Black Women

WomenIntimate Partner Violence (IPV)HIV Prevention+1 more
Johns Hopkins Bloomberg School of Public Health300 enrolled1 locationNCT06703060
Recruiting
Not Applicable

HIV Self-testing for Partners of HIV-uninfected Postpartum Women

FeasibilityHIV PreventionPrEP Uptake+3 more
Massachusetts General Hospital120 enrolled1 locationNCT07194902
Recruiting
Not Applicable

Safe Spaces 4 Sexual Health

HIV PreventionHIV Counseling and TestingHIV Risk Behavior
Johns Hopkins University100 enrolled2 locationsNCT07133555
Recruiting
Not Applicable

Using PrEP, Doing It for Ourselves

HIV PreventionPrEP
Duke University1,000 enrolled1 locationNCT06638892
Recruiting

HIV Outpatient Monitoring Evaluation Through Self-collection of Dried Blood Spots

HIV PreventionHIV Treatment
University of Colorado, Denver150 enrolled1 locationNCT04979728
Recruiting
Not Applicable

PrOTECT AL: PrEP Optimization Through Enhanced Continuum Tracking

HIVHIV PreventionPrEP+1 more
University of Alabama at Birmingham56 enrolled1 locationNCT07231640
Recruiting
Phase 1

Evaluation of Single Dosing With Two F/TAF Tablets Among Healthy Volunteers

Healthy VolunteerHIV Prevention
Johns Hopkins University24 enrolled1 locationNCT07349758
Recruiting
Phase 4

Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP

HIV Prevention
Duke University100 enrolled1 locationNCT07218211
Recruiting
Not Applicable

Enhancing HIV Prevention and Reducing Alcohol Use Among People Receiving STI Care in Lilongwe, Malawi

Alcohol ConsumptionHIV PreventionPrEP Uptake+2 more
University of North Carolina, Chapel Hill160 enrolled1 locationNCT06668363
Recruiting

Dat'Aids Prevention

HIV Prevention
DatAids6,500 enrolled31 locationsNCT03795376
Recruiting

The Unlocking PrEP Study: Integration of Peer Health Navigation Into Comprehensive Re-entry Services

HIV PreventionHIV Disease
University of Texas Southwestern Medical Center100 enrolled1 locationNCT07292792
Recruiting
Not Applicable

Testing a Gender-inclusive HIV Prevention Program

HIV Prevention
Center for Innovative Public Health Research200 enrolled1 locationNCT06586151
Recruiting
Not Applicable

Suubi4PrEP: Improving PrEP Access and Adherence Among Adolescent Girls and Young Women in Uganda

HIV Prevention
Washington University School of Medicine600 enrolled2 locationsNCT07002866